Florida ASCENT Program

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will adapt and implement MyCarePulse, an EHR-linked screening and referral platform, paired with ASCENT patient navigators who provide individualized support and connect patients to community nutrition resources. It will enroll about 200 adults with recent diagnoses of colorectal, prostate, lung, breast, gynecologic, hematologic, or skin cancers across UF Health and University of Miami systems in two phases: an implementation phase (Phase 1) and an intervention phase (Phase 2). Primary patient outcomes include food security, dietary self-efficacy, and diet quality, while provider-level outcomes examine feasibility, acceptability, and appropriateness. Phase 1 uses community-engaged participatory design and Expert Recommendations for Implementing Change (ERIC) strategies to refine the intervention before broader rollout.

Why it matters

Who can join: the full rules

Patient Eligibility Inclusion Criteria:

1. ≥18 years old.
2. Pathologically confirmed diagnosis, with a focus on, but not limited to, colorectal, prostate, lung, breast, gynecologic, hematologic, or skin (including melanoma) cancers.
3. Self-reported ability to read and speak English.
4. Able to provide informed consent.

Patient Eligibility Exclusion Criteria:

1. ≤18 years old.
2. Does not have a pathologically confirmed diagnosis of cancer.
3. Currently receiving active cancer treatment (e.g., active chemotherapy, radiation therapy or stem cell transplant); patients on stable maintenance therapy are eligible (e.g., endocrine therapy, targeted therapy, or select immunotherapy).

3\) Does not live within the state of Florida. 3) Does not self-reported ability to read and speak English or Spanish. 4) Not able to provide informed consent.

Provider Eligibility Inclusion Criteria

1. ≥18 years old.
2. Currently works as a physician, physician assistant, patient navigator and/or health system/administrative leader in UF and UM affiliated clinics.
3. Self-reported ability to read and speak English or Spanish.
4. Able to provide informed consent.

Provider Eligibility Exclusion Criteria

1. ≤ 18 years old.
2. Does not currently works as a physician, physician assistant, patient navigator and/or health system/administrative leader in UF and UM affiliated clinics.
3. Does not self-report having the ability to read and speak English.
4. Not able to provide informed consent.

Where it's running

• University of Florida
  Gainesville, Florida, United States Recruiting

Study contacts

• Study coordinator: Dejana Braithwaite, PhD, MSc
• Email: dbraithwaite@surgery.ufl.edu
• Phone: 4152165093

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

• IDOV-Immune for advanced solid tumors

  This trial will try a single IV infusion of an engineered oncolytic vaccinia virus called IDOV-Immune in adults with advanced solid tumors that no longer respond to standard treatments.

  Recruiting at 5 sites Phase 1 ViroMissile, Inc. · St Louis, Missouri and 4 other locations · NCT06910657

• Using brodalumab to treat immune-related side effects from cancer therapy

  This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06673329

• Understanding the experiences of patients with chronic cancer treatments

  This study is trying to understand how people with advanced chronic cancer feel about their targeted treatments by having them share their experiences through interviews and creative expressions like art and music.

  Recruiting University of Alberta · Edmonton, Alberta · NCT05645510

• A network for collaborative cancer research in Ontario

  This study is testing a new way to improve cancer treatment by using genetics and technology to help personalize care for people with different types of cancer.

  Recruiting at 2 sites University Health Network, Toronto · Kingston, Ontario and 2 other locations · NCT05403177

• Using blood tests to assess early treatment response in cancer patients

  This study is testing if blood tests that look for cancer DNA can help doctors see how well treatment is working for patients with different types of solid tumors.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT04354064

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.